SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?

To: 5,17,37,5,101,... who wrote (397)3/11/1999 11:23:00 AM
From: 5,17,37,5,101,...  Respond to of 2515
 
One more thing, the cost of developing drugs here is outrageously high. FDA is crazy. Why does it have to take on avg 6 yrs to get a drug approved? On avg it amounts to hunds of mills. These costs must be recouped in this market.



To: 5,17,37,5,101,... who wrote (397)3/11/1999 11:25:00 AM
From: Raven McCloud  Read Replies (1) | Respond to of 2515
 
Looks like IMCL just can't hold above $14.
I think we'll see a slow trickle back to
$12 with investors buying in on the descent
seeing value and other investors taking some
guaranteed profits.
IMCL could trade sideways to up if the mkt.
continues its climb to 10,000.
However, IMCL will be the first to collapse
in a mkt. downturn; just not strong enough
momentum to hold it.



HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News